Novel therapy delays muscle atrophy in Lou Gehrig’s disease model

July 13, 2018 GOSCIN 0Comments

Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig’s disease, according to a new study. Researchers found high levels of the protein — called mitofusion 2 or Mfn2 — prevented nerve degeneration, muscle atrophy, and paralysis in a mouse model of the disease. Since Mfn2 is often depleted during Lou Gehrig’s, the new study suggests supplementing it could be a novel therapeutic approach for the disease.

from Latest Science News — ScienceDaily https://ift.tt/2LaWjau
via IFTTT

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.